BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25952734)

  • 1. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
    Tavaré R; McCracken MN; Zettlitz KA; Salazar FB; Olafsen T; Witte ON; Wu AM
    J Nucl Med; 2015 Aug; 56(8):1258-64. PubMed ID: 25952734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Tavaré R; Escuin-Ordinas H; Mok S; McCracken MN; Zettlitz KA; Salazar FB; Witte ON; Ribas A; Wu AM
    Cancer Res; 2016 Jan; 76(1):73-82. PubMed ID: 26573799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
    Beckford Vera DR; Smith CC; Bixby LM; Glatt DM; Dunn SS; Saito R; Kim WY; Serody JS; Vincent BG; Parrott MC
    PLoS One; 2018; 13(3):e0193832. PubMed ID: 29513764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ImmunoPET Imaging of Murine CD4
    Freise AC; Zettlitz KA; Salazar FB; Lu X; Tavaré R; Wu AM
    Mol Imaging Biol; 2017 Aug; 19(4):599-609. PubMed ID: 27966069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.
    Tavaré R; McCracken MN; Zettlitz KA; Knowles SM; Salazar FB; Olafsen T; Witte ON; Wu AM
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1108-13. PubMed ID: 24390540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis.
    Freise AC; Zettlitz KA; Salazar FB; Tavaré R; Tsai WK; Chatziioannou AF; Rozengurt N; Braun J; Wu AM
    J Nucl Med; 2018 Jun; 59(6):980-985. PubMed ID: 29326360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical development of ZED8, an
    Ogasawara A; Kiefer JR; Gill H; Chiang E; Sriraman S; Ferl GZ; Ziai J; Bohorquez SS; Guelman S; Wang X; Yang J; Phan MM; Nguyen V; Chung S; Yu C; Tinianow J; Waaijer SJH; De Crespigny A; Marik J; Boswell CA; Zabka T; Staflin K; Williams SP
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):287-301. PubMed ID: 36271158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
    Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
    J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-PET Monitoring of CD8
    Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
    Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of
    Kol A; Fan X; Wazynska MA; van Duijnhoven SMJ; Giesen D; Plat A; Van Eenennaam H; Elsinga PH; Nijman HW; de Bruyn M
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with
    Leland P; Kumar D; Nimmagadda S; Bauer SR; Puri RK; Joshi BH
    J Transl Med; 2023 Jun; 21(1):367. PubMed ID: 37286997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
    Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-PET Imaging of
    Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
    Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Evaluation of
    Maresca KP; Chen J; Mathur D; Giddabasappa A; Root A; Narula J; King L; Schaer D; Golas J; Kobylarz K; Rosfjord E; Keliher E; Chen L; Ram S; Pickering EH; Hardwick JS; Rejto PA; Hussein A; Ilovich O; Staton K; Wilson I; McCarthy TJ
    Mol Imaging Biol; 2021 Dec; 23(6):941-951. PubMed ID: 34143379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4
    Islam A; Pishesha N; Harmand TJ; Heston H; Woodham AW; Cheloha RW; Bousbaine D; Rashidian M; Ploegh HL
    J Immunol; 2021 Sep; 207(5):1468-1477. PubMed ID: 34408009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054.
    Tavaré R; Danton M; Giurleo JT; Makonnen S; Hickey C; Arnold TC; Kelly MP; Fredriksson F; Bruestle K; Hermann A; Ullman E; Edelmann KH; Potocky T; Dudgeon D; Bhatt NB; Doubrovin M; Barry T; Kyratsous CA; Gurer C; Tu N; Gartner H; Murphy A; Macdonald LE; Popke J; Mintz A; Griesemer A; Olson WC; Thurston G; Ma D; Kirshner JR
    Cancer Immunol Res; 2022 Oct; 10(10):1190-1209. PubMed ID: 35895745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.